Akiyama Takenori, Takahashi Satoshi, Nagoshi Narihito, Ozawa Hiroyuki, Sasaki Hikaru, Toda Masahiro
Department of Neurosurgery, School of Medicine, Keio University, Tokyo, Japan.
Department of Orthopedics, School of Medicine, Keio University, Tokyo, Japan.
J Neuroendovasc Ther. 2021;15(5):316-322. doi: 10.5797/jnet.oa.2020-0140. Epub 2021 Jan 6.
Hemangiopericytomas (HPCs) and solitary fibrous tumors (SFTs) have been categorized as the same disease entity, SFT/HPC, since 2016. SFT/HPC is one of the most highly vascularized brain tumors, distinct from meningioma. The angioarchitecture also differs between these tumors. Understanding these differences can help interventionalists perform presurgical embolization more safely and effectively.
Vascular structures were analyzed in eight patients with central nervous system (CNS) SFT/HPCs, all of whom received presurgical embolization. The type of embolic materials used and the complication rates were compared between the CNS SFT/HPC cases and 39 meningioma cases treated within the same period. Characteristic angiographic features of SFT/HPC were identified, and we present their interpretation and utilization to inform embolization strategies.
Four angiographic features of SFT/HPCs were identified. 1) Persistence of tumor stain and 2) feeders from branches of the internal carotid artery or vertebral artery were observed in all cases, while 3) connecting feeders (highly dilated vessels that originate from branches of other feeder vessels and run along the surface of one tumor compartment to feed another compartment) were observed in five out of eight cases. 4) Finally, an intratumoral arteriovenous shunt was identified in one case. The frequency of liquid embolic material use was significantly higher in SFT/HPC cases than in meningioma cases. No complications were observed in SFT/HPC cases, and all tumors were effectively removed.
The most appropriate presurgical embolization strategies differ between SFT/HPCs and meningiomas depending on the tumor angioarchitecture. A thorough understanding of the vascular anatomy is necessary for safe and effective embolization of SFT/HPCs.
自2016年起,血管外皮细胞瘤(HPC)和孤立性纤维性肿瘤(SFT)被归类为同一疾病实体,即SFT/HPC。SFT/HPC是血管化程度最高的脑肿瘤之一,与脑膜瘤不同。这些肿瘤的血管结构也有所差异。了解这些差异有助于介入医生更安全、有效地进行术前栓塞。
对8例中枢神经系统(CNS)SFT/HPC患者的血管结构进行分析,所有患者均接受了术前栓塞。比较了CNS SFT/HPC病例与同期治疗的39例脑膜瘤病例所用栓塞材料的类型和并发症发生率。确定了SFT/HPC的特征性血管造影特征,并阐述其解读及应用,以为栓塞策略提供参考。
确定了SFT/HPC的四个血管造影特征。1)所有病例均观察到肿瘤染色持续存在;2)均可见来自颈内动脉或椎动脉分支的供血动脉;3)8例中有5例观察到连接供血动脉(起源于其他供血动脉分支、沿一个肿瘤区域表面走行以供血给另一个区域的高度扩张血管);4)最后,1例发现瘤内动静脉分流。SFT/HPC病例使用液体栓塞材料的频率显著高于脑膜瘤病例。SFT/HPC病例未观察到并发症,所有肿瘤均被有效切除。
根据肿瘤血管结构,SFT/HPC和脑膜瘤的最佳术前栓塞策略有所不同。全面了解血管解剖结构对于SFT/HPC的安全有效栓塞至关重要。